The legacy of Viagra offers a complex case study for stakeholders eyeing pharma. While first sales were remarkable, recent patent lapse and the arrival of generic versions have significantly impacted profitability. https://tiffanyhoat057425.atualblog.com/47699330/the-blue-pill-and-pharma-a-dangerous-investment